You are here

  • Home
  • Online First
  • Author’s response: Re ‘Mobile phone use and brain tumours in the CERENAT case–control study’

Article Text

Article menu

other Versions

Download PDFPDF
PostScript
Letter
Author’s response: Re ‘Mobile phone use and brain tumours in the CERENAT case–control study’
  1. Gaëlle Coureau1,2,3,
  2. Karen Leffondre2,
  3. Anne Gruber1,
  4. Ghislaine Bouvier1,2,
  5. Isabelle Baldi1,2,4
  1. 1Laboratoire Santé Travail Environnement, Univ Bordeaux, ISPED, Bordeaux, France
  2. 2INSERM, ISPED, Centre INSERM U897-Epidémiologie-Biostatistique, Bordeaux, France
  3. 3Service d'information médicale, CHU de Bordeaux, Bordeaux, France
  4. 4Service de Médecine du Travail, CHU de Bordeaux, Bordeaux, France
  1. Correspondence to Dr Gaëlle Coureau, Université de Bordeaux, ISPED, Laboratoire Santé Travail Environnement, 146 rue Léo Saignat, Bordeaux Cedex 33076, France; gaelle.coureau{at}isped.u-bordeaux2.fr

https://doi.org/10.1136/oemed-2014-102649

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We thank Dr Hardell for his comment1 on our article concerning analyses regarding head position of mobile phone use.2

    In our analysis on ipsilateral use, we included cases who used their mobile phone on the same side as the tumour or on both sides of the head, cases who were not regular users (the reference category) and all their matched controls. In our analysis on contralateral use, we used cases who used their mobile phone on the opposite side as the tumour, cases who were not …

    View Full Text

    Footnotes

    • Funding The study was supported by grants from the Fondation de France, the Agence Française de Sécurité Sanitaire de l’Environnement et du Travail, the Association pour la Recherche contre le Cancer, the Ligue contre le Cancer, the Institut National de la Santé Et de la Recherche Médicale—ATC Environnement et Santé.

    • Competing interests None.

    • Patient consent Obtained.

    • Ethics approval CCTIRS, CNIL.

    • Provenance and peer review Not commissioned; internally peer reviewed.

    Linked Articles